Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "(Ł)" wg kryterium: Autor


Tytuł:
„Ab initio” study of helium atoms immobilization in UO2 crystals
Autorzy:
Dąbrowski, L.
Szuta, M.
Powiązania:
https://bibliotekanauki.pl/articles/146654.pdf
Data publikacji:
2012
Wydawca:
Instytut Chemii i Techniki Jądrowej
Tematy:
uranium
dioxide
DFT+U
LDA
GGA
ABINIT
over-barrier jumps
incorporated helium
harmonic oscillator
Opis:
We present density functional theory (DFT) calculation results concerning the uranium dioxide crystals with a helium atom incorporated in the octahedral interstitial position. "Ab initio" calculations were performed using the Wien2k program package. For comparison, a pseudo-potential approach in the generalized gradient approximation was applied using the ABINIT program package. To compute the unit cell parameters 13 atom super-cell was chosen. Parameters of the potential barrier, which the helium atom has to overcome while jumping to the next octahedral interstitial position, were calculated by the help of both the program packages. The results, obtained using two different program packages, are shown in the table and presented graphically. For the so described parameters, the quantum mechanical movement of the helium atom around the equilibrium position is considered. The parameters of Schrödinger's equation are collected in Table 2, while the results of mean square deviation and thermal occupation of energetic levels are presented in a graph. It is established that the helium atoms are located (with an accuracy of several percent of lattice constant) nearby the equilibrium position and form a local bound state. Applying a two site-model, we evaluated the time for an over-barrier jump. Graphically presented results show that the helium atom over-barrier jump is not possible even for temperatures as high as 1200 K. Influence of potential barrier height on the jump time was also considered.
Źródło:
Nukleonika; 2012, 57, 3; 337-343
0029-5922
1508-5791
Pojawia się w:
Nukleonika
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
“Consciousness in Its Own Self Provides Its Own Standard”. Hegel and the Spirit as a Process of Thinking
Autorzy:
Waibel, Violetta L.
Powiązania:
https://bibliotekanauki.pl/articles/2141934.pdf
Data publikacji:
2022-07-28
Wydawca:
Uniwersytet im. Adama Mickiewicza w Poznaniu
Opis:
Hegel’s Phenomenology of Spirit develops not only the idea of absolute knowledge but also the notion of an inner criterion [Maßstab] of the spirit. The inner criterion or norm of knowledge is what, in the end of the speculative process, appears as the form of absolute knowledge. Experience and inner criterion are responsible for the development of the consciousness that has to become itself. Becoming and absolute, temporality and timelessness are the substance that becomes and is subject. The actuality of this method of analysis of spirit will be shown and discussed in this essay.
Źródło:
Ethics in Progress; 2022, 13, 1; 41-56
2084-9257
Pojawia się w:
Ethics in Progress
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
„Iron Heart”: Reversible Cause of Dilated Cardiomyopathy Secondary to Cardiac Toxicity in Elderly Patient with Myelodysplastic Syndrome
Autorzy:
Martin-Garcia, Ana
Alonso Fernandez de Gatta, Marta
Diez-Campelo, María
Martín-García, Agustín C.
Barreiro Pérez, Manuel
Diaz-Pelaez, Elena
López Cadenas, Félix
Sanchez, Pedro L.
Powiązania:
https://bibliotekanauki.pl/articles/1035672.pdf
Data publikacji:
2019
Wydawca:
Medical Education
Tematy:
advanced prostate cancer
androgen depravation therapy
triptorelin
Opis:
Triptorelin as the luteinizing hormone releasing hormone (LHRH) analogue has its own place among other available forms of androgen-depravation therapy (ADT) of locally advanced and metastatic prostate cancer (PCa). Nowadays, in times of development of new therapies in castration-resistant PCa, ADT remains the back bone therapy, which may be supplemented with one of novel drugs. The results of basic research indicate, that apart from the main mechanism of action based on lowering a testosterone concentration to the castration level, triptorelin may have a direct inhibitory effect on tumor cells. Formulations of tryptorelin are available to administer as 1-month, 3-months and 6-months sustained-release forms that may be given intramuscularly or subcutaneously. Constant concentration of triptoreline is maintained by using special microspheres in drug production. Pharmacokinetic and pharmacodynamic properties of particular forms were extensively tested, which allows for safe usage and retain of predictable and high efficacy. Indicators of effective ADT are fast reduction and maintenance of the state of castration. This phenomenon translates into a decrease of the prostate-specific antigen and longer survival. Triptorelin successfully meets these objectives based on a number of phase I–III studies. There is a noticeable lack of comparative studies on effectiveness of particular ADT forms. This may stem from an assumption, that all LHRH analogues demonstrate similar effectiveness because of the class effect. However, some evidence highlight significant differences in efficacy among these drugs. Triptorelin compares especially favourably, particularly as a drug reducing the testosterone level to the lower recommended values (< 20 ng/dl). Side effect profile during the therapy with triptorelin is largely the result of inhibition of the hypothalamic- pituitary-testicular axis. Hormonal disturbances linked to hipoandrogenism cause changes in lipid metabolism and glucose tolerance, which may influence the cardiovascular risk. This article is a review of key reports regarding triptorelin and a summary of the role that triptorelin plays in contemporary ADT in advanced PCa.
Źródło:
OncoReview; 2019, 9, 4; 88-91
2450-6125
Pojawia się w:
OncoReview
Dostawca treści:
Biblioteka Nauki
Artykuł

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies